A Multiplex Snapback Primer System for the Enrichment and Detection of JAK2 V617F and MPL W515L/K Mutations in Philadelphia-Negative Myeloproliferative Neoplasms

被引:5
|
作者
Wu, Zhiyuan [1 ,2 ]
Zhang, Yunqing [3 ]
Zhang, Xinju [1 ]
Xu, Xiao [1 ]
Kang, Zhihua [4 ]
Li, Shibao [4 ]
Zhang, Chen [2 ]
Su, Bing [5 ]
Guan, Ming [1 ,2 ,4 ]
机构
[1] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Cent Lab, Shanghai 200433, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Huashan Hosp North, Dept Lab Med, Shanghai 200433, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Dermatol, Guangzhou 510275, Guangdong, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Dept Lab Med, Shanghai 200433, Peoples R China
[5] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA
关键词
WORLD-HEALTH-ORGANIZATION; TYROSINE KINASE JAK2; EXON; 10; ESSENTIAL THROMBOCYTHEMIA; SENSITIVE DETECTION; MELTING ANALYSIS; MODIFIED PROBES; TIME; POLYMERASE; DNA;
D O I
10.1155/2014/458457
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A multiplex snapback primer system was developed for the simultaneous detection of JAK2 V617F and MPL W515L/K mutations in Philadelphia chromosome-(Ph-) negative myeloproliferative neoplasms (MPNs). The multiplex system comprises two snapback versus limiting primer sets for JAK2 and MPL mutation enrichment and detection, respectively. Linear-After exponential (LATE) PCR strategy was employed for the primer design to maximize the amplification efficiency of the system. Low ionic strength buffer and rapid PCR protocol allowed for selective amplification of the mutant alleles. Amplification products were analyzed by melting curve analysis for mutation identification. The multiplex system archived 0.1% mutation load sensitivity and <5% coefficient of variation inter-/intra-assay reproducibility. 120 clinical samples were tested by the multiplex snapback primer assay, and verified with amplification refractory system (ARMS), quantitative PCR (qPCR) and Sanger sequencing method. The multiplex system, with a favored versatility, provided the molecular diagnosis of Ph-negative MPNs with a suitable implement and simplified the genetic test process.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myetoproliferative disorders with JAK2 V617F
    Gibson, Sarah E.
    Schade, Andrew E.
    Szpurka, Hadrian
    Bak, Beata
    Maciejewski, Jaroslaw P.
    Hsi, Eric D.
    HUMAN PATHOLOGY, 2008, 39 (07) : 1111 - 1114
  • [32] Evaluation of V617F mutation of JAK2 in negative chromosome Philadelphia chronic myeloproliferative disorders
    Remacha, Angel F.
    Puget, Guiomar
    Nomdedeu, Josep F.
    Estivill, Camino
    Pilar Sarda, M.
    Canals, Carme
    MEDICINA CLINICA, 2006, 127 (16): : 601 - 604
  • [33] Allelefrequencies of JAK2V617F and MpIW515L/K mutations in Philadelphia negative chronic myeloproliferative disorders
    Bock, O.
    Hussein, K.
    Buesche, G.
    Buhr, T.
    Wiese, B.
    Kreipe, H.
    PATHOLOGY RESEARCH AND PRACTICE, 2007, 203 (05) : 265 - 265
  • [34] The JAK2 V617F mutational status and allele burden may be related with the risk of venous thromboembolic events in patients with Philadelphia-negative myeloproliferative neoplasms
    Borowczyk, Martyna
    Wojtaszewska, Marzena
    Lewandowski, Krzysztof
    Gil, Lidia
    Lewandowska, Maria
    Lehmann-Kopydlowska, Agata
    Kroll-Balcerzak, Renata
    Balcerzak, Andrzej
    Iwola, Malgorzata
    Michalak, Michal
    Komarnicki, Mieczyslaw
    THROMBOSIS RESEARCH, 2015, 135 (02) : 272 - 280
  • [35] Familial Essential Thrombocythemia Associated withMPL W515L Mutation in Father and JAK2 V617F Mutation in Daughter
    Trifa, Adrian P.
    Cucuianu, Andrei
    Popp, Radu A.
    CASE REPORTS IN HEMATOLOGY, 2014, 2014
  • [36] Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
    Yoenal-Hindilerden, Ipek
    Sahin, Ezgi
    Hindilerden, Fehmi
    Daglar-Aday, Aynur
    Nalcaci, Meliha
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 (03) : 174 - 182
  • [37] Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report
    Waiswa, Musa
    Seremba, Emmanuel
    Ocama, Ponsiana
    Ddungu, Henry
    Opio, Keneth
    Okello, Clement
    O'shea, Timothy
    Verhovsek, Madeleine
    Mutyabule, Richard
    AFRICAN HEALTH SCIENCES, 2014, 14 (04) : 1069 - 1073
  • [38] Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
    Bench, Anthony J.
    White, Helen E.
    Foroni, Letizia
    Godfrey, Anna L.
    Gerrard, Gareth
    Akiki, Susanna
    Awan, Abida
    Carter, Ian
    Goday-Fernandez, Andrea
    Langabeer, Stephen E.
    Clench, Tim
    Clark, Jordan
    Evans, Paul A.
    Grimwade, David
    Schuh, Anna
    McMullin, Mary F.
    Green, Anthony R.
    Harrison, Claire N.
    Cross, Nicholas C. P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (01) : 25 - 34
  • [39] Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations
    Makarik, Tatiana, V
    Abdullaev, Adhamjon O.
    Nikulina, Elena E.
    Treglazova, Svetlana A.
    Stepanova, Elena E.
    Subortseva, Irina N.
    Kovrigina, Alla M.
    Melikyan, Anait L.
    Kulikov, Sergei M.
    Sudarikov, Andrey B.
    GENES, 2021, 12 (04)
  • [40] Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
    Yonal-Hindilerden, Ipek
    Daglar-Aday, Aynur
    Akadam-Teker, Basak
    Yilmaz, Ceylan
    Nalcaci, Meliha
    Yavuz, Akif Selim
    Sargin, Deniz
    JOURNAL OF BLOOD MEDICINE, 2015, 6 : 157 - 175